These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12386229)

  • 1. Section V. Chronic intermittent haemodialysis and prevention of clotting in the extracorporal system.
    European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association
    Nephrol Dial Transplant; 2002; 17 Suppl 7():63-71. PubMed ID: 12386229
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors of system clotting in heparin-free haemodialysis.
    Keller F; Seemann J; Preuschof L; Offermann G
    Nephrol Dial Transplant; 1990; 5(9):802-7. PubMed ID: 2129354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitigation of coagulation by removing clotting factors part 2: heparin-free extracorporeal circulation in a porcine model.
    Sukavaneshvar S; Parker JT; Beutler DS; Burns G; Solen KA; Mohammad SF
    ASAIO J; 2007; 53(4):421-7. PubMed ID: 17667225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of factors related to hemodialysis on certain blood-coagulation parameters].
    Koslik S; Moscovic F; Matejícková G
    Z Urol Nephrol; 1978 May; 71(5):339-44. PubMed ID: 676538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
    Skagerlind MSE; Stegmayr BG
    Eur J Clin Pharmacol; 2018 Mar; 74(3):267-274. PubMed ID: 29198062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation therapy during haemodialysis: a comparative study between two heparin regimens.
    Sabry A; Taha M; Nada M; Al Fawzan F; Alsaran K
    Blood Coagul Fibrinolysis; 2009 Jan; 20(1):57-62. PubMed ID: 20523166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparin.
    Anastassiades E; Ireland H; Flynn A; Lane DA; Curtis JR
    Nephrol Dial Transplant; 1990; 5(2):135-40. PubMed ID: 2162506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
    Ryckelynck JP; Chouraqui D; Lobbedez T
    Nephrologie; 1998; 19(4):223-5. PubMed ID: 9675763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin.
    Sagedal S; Hartmann A; Osnes K; Bjørnsen S; Torremocha J; Fauchald P; Kofstad J; Brosstad F
    Nephrol Dial Transplant; 2006 Feb; 21(2):444-9. PubMed ID: 16234293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.
    Meijers B; Metalidis C; Vanhove T; Poesen R; Kuypers D; Evenepoel P
    Nephrol Dial Transplant; 2017 Apr; 32(4):707-714. PubMed ID: 28407129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional Citrate Anticoagulation for Intermittent Hemodialysis in Dogs.
    Francey T; Schweighauser A
    J Vet Intern Med; 2018 Jan; 32(1):147-156. PubMed ID: 29171099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single dose of dalteparin effectively prevents clotting during haemodialysis.
    Sagedal S; Hartmann A; Sundstrøm K; Bjørnsen S; Fauchald P; Brosstad F
    Nephrol Dial Transplant; 1999 Aug; 14(8):1943-7. PubMed ID: 10462275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of prostacyclin in extracorporeal circulation.
    Ede RJ; Hughes RD; Williams R
    Int J Artif Organs; 1985 Nov; 8(6):297-300. PubMed ID: 3908327
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful clinical application of extracorporal albumin dialysis in a patient with benign recurrent intrahepatic cholestasis (BRIC).
    Huster D; Schubert C; Achenbach H; Caca K; Mössner J; Berr F
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():13-4. PubMed ID: 16215886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodialysis in patients treated with oral anticoagulant: should we heparinize?
    Krummel T; Scheidt E; Borni-Duval C; Bazin D; Lefebvre F; Nguyen P; Hannedouche T
    Nephrol Dial Transplant; 2014 Apr; 29(4):906-13. PubMed ID: 24459138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of coagulation during hemodialysis: effect of blood lines alone and whole extracorporeal circuit.
    Lucchi L; Ligabue G; Marietta M; Delnevo A; Malagoli M; Perrone S; Stipo L; Grandi F; Albertazzi A
    Artif Organs; 2006 Feb; 30(2):106-10. PubMed ID: 16433843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in coagulation, fibrinolysis and platelet functions during extracorporeal circulation].
    Kaizu K; Uriu K; Ikeda M
    Nihon Rinsho; 2004 May; 62 Suppl 5():46-9. PubMed ID: 15197886
    [No Abstract]   [Full Text] [Related]  

  • 19. Fondaparinux as an alternative to vitamin K antagonists in haemodialysis patients.
    Speeckaert MM; Devreese KM; Vanholder RC; Dhondt A
    Nephrol Dial Transplant; 2013 Dec; 28(12):3090-5. PubMed ID: 24021678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics in extracorporeal blood purification and peritoneal dialysis.
    Thongboonkerd V
    J Proteomics; 2010 Jan; 73(3):521-6. PubMed ID: 19527805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.